Impact of Beta-blockers on Physical Function in HFpEF

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 28, 2022

Study Completion Date

April 28, 2023

Conditions
Heart FailureHeart Failure, DiastolicHeart Failure With Preserved Ejection FractionCardiac FailureHeart Disease
Interventions
DRUG

Beta blockers

"The intervention is a two-arm crossover withdrawal/ reversal design (On \[A\] vs Off \[B\]) with up to 4 periods, each period lasting up to 6 weeks. During the On period (A), subjects will be on their beta blocker. During the Off period (B), their beta blockers will be down titrated and subsequently discontinued.~Subjects will be randomized into either ABAB or BABA sequences."

Trial Locations (1)

10021

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

The New York Community Trust

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT04767061 - Impact of Beta-blockers on Physical Function in HFpEF | Biotech Hunter | Biotech Hunter